$MHUA
Meihua International Medical Technologies Co., Ltd. Stock $mhua

$mhua Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023029709 Filed on April 14, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$103.3M	$103.3M
YoY Change		-0.66%
Cost Of Revenue	$65.25M	$65.25M
YoY Change		1.58%
Gross Profit	$38.10M	$38.10M
YoY Change		-4.29%
Gross Profit Margin	36.86%	36.86%
Selling, General & Admin	$19.45M	$19.58M
YoY Change		83.92%
% of Gross Profit	51.06%	51.39%
Research & Development	$2.955M	$2.963M
YoY Change		9.06%
% of Gross Profit	7.76%	7.78%
Depreciation & Amortization	$134.8K	$541.3K
YoY Change		-13.05%
% of Gross Profit	0.35%	1.42%
Operating Expenses	$27.30M	$27.30M
YoY Change		101.54%
Operating Profit	$10.80M	$10.80M
YoY Change		-58.87%
Interest Expense	$142.5K	$142.5K
YoY Change		712.84%
% of Operating Profit	1.32%	1.32%
Other Income/Expense, Net	-$53.21K	-$89.29K
YoY Change		77.01%
Pretax Income	$10.89M	$10.89M
YoY Change		-58.47%
Income Tax	$4.714M	$4.714M
% Of Pretax Income	43.28%	43.28%
Net Earnings	$6.243M	$6.243M
YoY Change		-70.2%
Net Earnings / Revenue	6.04%	6.04%
Basic Earnings Per Share		$0.27
Diluted Earnings Per Share	$0.27	$0.27
COMMON SHARES
Basic Shares Outstanding	23.94M shares	23.41M shares
Diluted Shares Outstanding		23.41M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.74M	$26.74M
YoY Change		228.09%
Cash & Equivalents	$26.74M		$8.149M
Short-Term Investments
Other Short-Term Assets	$16.43M	$16.43M
YoY Change		1078.08%
Inventory	$1.122M	$1.122M	$1.251M
Prepaid Expenses
Receivables	$68.95M	$68.95M	$67.10M
Other Receivables	$239.1K	$22.09M	$117.4K
Total Short-Term Assets	$135.3M	$135.3M	$97.28M
YoY Change	39.11%	39.11%	43.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.758M	$8.758M	$7.478M
YoY Change	17.12%	17.12%	5.28%
Goodwill
YoY Change
Intangibles	$497.6K		$562.0K
YoY Change	-11.46%
Long-Term Investments	$6.670M	$6.670M
YoY Change		608.39%
Other Assets	$12.33M	$12.33M
YoY Change		-59.7%
Total Long-Term Assets	$28.26M	$28.26M	$39.58M
YoY Change	-28.61%	-28.61%	2.85%
TOTAL ASSETS
Total Short-Term Assets	$135.3M	$135.3M	$97.28M
Total Long-Term Assets	$28.26M	$28.26M	$39.58M
Total Assets	$163.6M	$163.6M	$136.9M
YoY Change	19.52%	19.52%	29.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.10M	$16.10M	$20.98M
YoY Change	-23.28%	-23.28%	34.17%
Accrued Expenses	$1.238M	$1.238M
YoY Change		-7.33%
Deferred Revenue
YoY Change
Short-Term Debt	$6.089M	$6.089M	$5.178M
YoY Change	17.59%	17.59%	60.9%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.17M	$24.17M	$29.09M
YoY Change	-16.9%	-16.9%	36.48%
LONG-TERM LIABILITIES
Long-Term Debt	$724.9K	$724.9K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$724.9K	$724.9K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.17M	$24.17M	$29.09M
Total Long-Term Liabilities	$724.9K	$724.9K
Total Liabilities	$24.90M	$25.45M	$29.09M
YoY Change	-14.41%	-12.49%	36.48%
SHAREHOLDERS EQUITY
Retained Earnings	$83.33M		$77.57M
YoY Change	7.42%
Common Stock	$11.97K		$10.00K
YoY Change	19.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$138.1M	$138.1M	$107.8M
YoY Change
Total Liabilities & Shareholders Equity	$163.6M	$163.6M	$136.9M
YoY Change	19.52%	19.52%	29.05%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$6.243M	$6.243M
YoY Change		-70.2%
Depreciation, Depletion And Amortization	$134.8K	$541.3K
YoY Change		-13.05%
Cash From Operating Activities		-$9.163M
YoY Change		16663.7%
INVESTING ACTIVITIES
Capital Expenditures		$2.699M
YoY Change		-417.41%
Acquisitions
YoY Change
Other Investing Activities		-$5.922M
YoY Change		-36185.07%
Cash From Investing Activities		-$8.620M
YoY Change		933.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$37.25M
YoY Change		1902.2%
NET CHANGE
Cash From Operating Activities		-$9.163M
Cash From Investing Activities		-$8.620M
Cash From Financing Activities		$37.25M
Net Change In Cash		$18.59M
YoY Change		1812.78%
FREE CASH FLOW
Cash From Operating Activities		-$9.163M
Capital Expenditures		$2.699M
Free Cash Flow		-$11.86M
YoY Change		-1590.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20000000	shares
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Touqiao Town
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Guangling District
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Yangzhou
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	225000
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022	dei	Security12b Title Security12bTitle	Ordinary Share, $0.0005 par value
CY2022	dei	Trading Symbol TradingSymbol	MHUA
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41291
CY2022	dei	Entity Registrant Name EntityRegistrantName	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	88 Tongda Road
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23940000	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	6651
CY2022	dei	Auditor Name AuditorName	Kreit & Chiu CPA LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26736700	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8149276	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	22085846	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	19379845	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	68945792	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	67101297	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1122038	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1251393	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16428779	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1394539	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	135319155	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	97276350	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8758047	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7477744	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	497600	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	562001	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	6669655	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	941531	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12333122	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	30599755	usd
CY2022Q4	us-gaap	Assets Assets	163577579	usd
CY2021Q4	us-gaap	Assets Assets	136857381	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6089428	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5178420	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16096165	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20981041	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1131276	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2082252	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	856698	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	847066	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24173567	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29088779	usd
CY2022Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	724932	usd
CY2022Q4	us-gaap	Liabilities Liabilities	24898499	usd
CY2021Q4	us-gaap	Liabilities Liabilities	29088779	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23940000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23940000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11970	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42967006	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9716484	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	15665860	usd
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	15178467	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	83330239	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	77574663	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3852138	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5288988	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	138122937	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	107768602	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	556143	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138679080	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	107768602	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163577579	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	136857381	usd
CY2022	mhua	Revenue From Third Party Sales RevenueFromThirdPartySales	103317145	usd
CY2021	mhua	Revenue From Third Party Sales RevenueFromThirdPartySales	103461809	usd
CY2020	mhua	Revenue From Third Party Sales RevenueFromThirdPartySales	88244403	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	29196	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	575901	usd
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	816607	usd
CY2022	us-gaap	Revenues Revenues	103346341	usd
CY2021	us-gaap	Revenues Revenues	104037710	usd
CY2020	us-gaap	Revenues Revenues	89061010	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	65247864	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	64232469	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	51900823	usd
CY2022	us-gaap	Gross Profit GrossProfit	38098477	usd
CY2021	us-gaap	Gross Profit GrossProfit	39805241	usd
CY2020	us-gaap	Gross Profit GrossProfit	37160187	usd
CY2022	us-gaap	Selling Expense SellingExpense	7109524	usd
CY2021	us-gaap	Selling Expense SellingExpense	6457801	usd
CY2020	us-gaap	Selling Expense SellingExpense	6624332	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12468551	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4361472	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4577570	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2962904	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2725014	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2492059	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4755536	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	27296515	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	13544287	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	13693961	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	10801962	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	26260954	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	23466226	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	194667	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	180744	usd
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	137160	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	63725	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	23855	usd
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	36583	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-273432	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-174413	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-393478	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	53205	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	50437	usd
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	25551	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-89285	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	32913	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-267350	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10891247	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26228041	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23733576	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4713543	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5278462	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4688321	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6177704	usd
CY2021	us-gaap	Profit Loss ProfitLoss	20949579	usd
CY2020	us-gaap	Profit Loss ProfitLoss	19045255	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-65265	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6242969	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	20949579	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	19045255	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9155028	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2083243	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4759973	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2977324	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	23032822	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	23805228	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-79167	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2898157	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23032822	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23805228	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23411068	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20000000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20000000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	59658320	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1616971	usd
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-344739	usd
CY2020	us-gaap	Profit Loss ProfitLoss	19045255	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4759973	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	84735780	usd
CY2021	us-gaap	Profit Loss ProfitLoss	20949579	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2083243	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	107768602	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	33252492	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	635310	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6177704	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-9155028	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138679080	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6177704	usd
CY2021	us-gaap	Profit Loss ProfitLoss	20949579	usd
CY2020	us-gaap	Profit Loss ProfitLoss	19045255	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	541265	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	595522	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	497238	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22196	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26951	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26195	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-25023	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-15281	usd
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2852	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4755536	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	273432	usd
CY2022	mhua	Bank Acceptance Receivables BankAcceptanceReceivables	4284515	usd
CY2021	mhua	Bank Acceptance Receivables BankAcceptanceReceivables	6533717	usd
CY2020	mhua	Bank Acceptance Receivables BankAcceptanceReceivables	5764940	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7121889	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20065904	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13644830	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-35027	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-105121	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	219787	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4932145	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	861799	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	367249	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-396583	usd
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	222504	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3371275	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4908971	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5341710	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-812412	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	288659	usd
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	598105	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	75879	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	120090	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	102749	usd
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-68798	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9163038	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54663	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5325996	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2698729	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	850231	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3808259	usd
CY2020	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	12311347	usd
CY2022	mhua	Long Term Investment LongTermInvestment	5944709	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	23146	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16414	usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25202	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8620292	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-833817	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16094404	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7579135	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	6510820	usd
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4359665	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	743052	usd
CY2022	mhua	Capital Contributed By Noncontrolling Shareholders CapitalContributedByNoncontrollingShareholders	635310	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	34529644	usd
CY2020	mhua	Proceeds From Issuance Of Shares ProceedsFromIssuanceOfShares	-1272232	usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	6241641	usd
CY2021	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	4650586	usd
CY2020	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	3925147	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37245500	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1860234	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1706750	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-874746	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9812	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218137	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18587424	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	961942	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8843521	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8149276	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7187334	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16030855	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26736700	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8149276	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7187334	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	194667	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	180744	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	137160	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	5703288	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	5042816	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	4362169	usd
CY2022	mhua	Shareholder Contribution Through Deferred Cost ShareholderContributionThroughDeferredCost	1277152	usd
CY2015Q4	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	53911815	hkd
CY2015Q4	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	6911771	usd
CY2021Q4	mhua	Subsidiary Percentage SubsidiaryPercentage	0.55	pure
CY2020Q4	mhua	Description Of Yongjun Liu Surrendered Shares DescriptionOfYongjunLiuSurrenderedShares	Yongjun Liu surrendered 49,999 shares to the Company for cancellation. The Company subdivided each existing share with a par value of $1.00 into 2,000 shares with a par value of $0.0005 par value and created a new class of preferred shares. Upon completion of the share capital changes, the Company’s share capital includes 80,000,000 ordinary shares with a par value of $0.0005 per share and 20,000,000 preferred shares with a par value of $0.0005 per share.
CY2020Q4	mhua	Description Of Corporate Reorganization DescriptionOfCorporateReorganization	the Company engaged in a corporate reorganization to combine the controlled entities (now referred to as the subsidiaries) into one legal corporation (the Company). The specific transactions related to this reorganization are outlined below. The Company entered into a share exchange agreement with Kang Fu to issue an aggregate of 15,933,000 ordinary shares to Yongjun Liu and Yin Liu in exchange for 100% ownership of Kang Fu, and allotted 2,640,000 ordinary shares at $0.0005 par value to three BVI companies held by founders of the Company for no consideration. On December 22, 2020, Guanghui was incorporated for the purpose of foreign exchange registration under the laws of the People’s Republic of China as there was no substantive business of Guanghui. The shares of Guanghui are owned by 13 natural persons (the “Guanghui Shareholders”) and on May 10, 2021, all of the Guanghui Shareholders agreed to transfer all their shares held in Guanghui to Huadong (an indirect subsidiary of the Company) for no consideration.
CY2022	mhua	Ordinary Share OrdinaryShare	18575000	shares
CY2020Q4	mhua	Total Issued TotalIssued	1425000	shares
CY2020Q4	mhua	Total Consideration TotalConsideration	1616971	usd
CY2022	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1616971	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and related notes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most significant estimates and judgments include allowance for bad debts, the valuation of inventory, useful life of property, plant and equipment and income taxes related to realization of deferred tax assets and uncertain tax position. Actual amounts could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	mhua	Period Ended Spot PeriodEndedSpot	1	usd
CY2022	mhua	Period Ended Spots PeriodEndedSpots	6.8972
CY2021	mhua	Period Ended Spot PeriodEndedSpot	1	usd
CY2021	mhua	Period Ended Spots PeriodEndedSpots	6.3726
CY2020	mhua	Period Ended Spot PeriodEndedSpot	1	usd
CY2020	mhua	Period Ended Spots PeriodEndedSpots	6.525
CY2022	mhua	Period Average PeriodAverage	1	usd
CY2022	mhua	Period Averages PeriodAverages	6.729
CY2021	mhua	Period Average PeriodAverage	1	usd
CY2021	mhua	Period Averages PeriodAverages	6.4508
CY2020	mhua	Period Average PeriodAverage	1	usd
CY2020	mhua	Period Averages PeriodAverages	6.9042
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain Risks and Concentration</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and receivables. As of December 31, 2022 and 2021 substantially all the Company’s cash were held in major financial institutions located in Hong Kong and the PRC, which management considers to be of high credit quality.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, two customers accounted for approximately 27.63% and 10.97% of the Company’s total revenues. As of December 31, 2021, two customers accounted for approximately 21.91% and 11.26% of the Company’s total revenues.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, two customers accounted for approximately 27.73% and 13.14% of the Company’s accounts receivable. As of December 31, 2021, three customers accounted for approximately 25.88%, 11.41% and 10.25%, respectively, of the Company’s accounts receivable. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022, one supplier accounted for approximately 11.93% of the Company’s total purchases There were no suppliers that individually represented greater than 10% of the total purchase of the Group for the years ended December 31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Cash	9600000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	560119	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	682699	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	40650	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	38592	usd
CY2022	mhua	Prepayments And Other Current Assets PrepaymentsAndOtherCurrentAssets	16428779	usd
CY2021	mhua	Prepayments And Other Current Assets PrepaymentsAndOtherCurrentAssets	1394539	usd
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	1277152	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1122038	usd
CY2011Q1	mhua	Equity Interest Percentage EquityInterestPercentage	0.12	pure
CY2022	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	290	usd
CY2019Q2	mhua	Current Vat Rate Percentage CurrentVatRatePercentage	0.13	pure
CY2021Q4	us-gaap	Other Investments OtherInvestments	1251393	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	15058	usd
CY2022	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	103346341	usd
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	104037710	usd
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	89061010	usd
CY2022	mhua	Direct Sales DirectSales	9465644	usd
CY2021	mhua	Direct Sales DirectSales	9499748	usd
CY2020	mhua	Direct Sales DirectSales	9430082	usd
CY2022	mhua	Distributors Distributors	93880697	usd
CY2021	mhua	Distributors Distributors	94537962	usd
CY2020	mhua	Distributors Distributors	79630928	usd
CY2022	us-gaap	Revenues Revenues	103346341	usd
CY2021	us-gaap	Revenues Revenues	104037710	usd
CY2020	us-gaap	Revenues Revenues	89061010	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	988264	usd
CY2022	mhua	Less Accumulated Amortization LessAccumulatedAmortization	415497	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	95432	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	21498	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	53770	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2962904	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2725014	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2492059	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2022	mhua	One Operating Segment OneOperatingSegment	the Company has determined that it has only one operating segment
CY2021	mhua	Less Accumulated Amortization LessAccumulatedAmortization	426263	usd
CY2022Q4	mhua	Intangible Assets Net IntangibleAssetsNet	497600	usd
CY2021Q4	mhua	Intangible Assets Net IntangibleAssetsNet	562001	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22196	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26951	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26195	usd
CY2022	mhua	Produced Produced	50514976	usd
CY2022	mhua	Purchased Purchased	52831365	usd
CY2022	mhua	Revenue Total RevenueTotal	103346341	usd
CY2021	mhua	Produced Produced	48059165	usd
CY2021	mhua	Purchased Purchased	55978545	usd
CY2021	mhua	Revenue Total RevenueTotal	104037710	usd
CY2020	mhua	Produced Produced	44473076	usd
CY2020	mhua	Purchased Purchased	44587934	usd
CY2020	mhua	Revenue Total RevenueTotal	89061010	usd
CY2022	mhua	Others Products OthersProducts	10849537	usd
CY2021	mhua	Others Products OthersProducts	9065588	usd
CY2020	mhua	Others Products OthersProducts	5172805	usd
CY2022	mhua	Total Products TotalProducts	103346341	usd
CY2021	mhua	Total Products TotalProducts	104037710	usd
CY2020	mhua	Total Products TotalProducts	89061010	usd
CY2022	mhua	Total Revenues And Assets Percentage TotalRevenuesAndAssetsPercentage	0.995	pure
CY2021	mhua	Total Revenues And Assets Percentage TotalRevenuesAndAssetsPercentage	0.995	pure
CY2020	mhua	Total Revenues And Assets Percentage TotalRevenuesAndAssetsPercentage	0.995	pure
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	15058	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	239148	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	117389	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	250410	usd
CY2022Q4	mhua	Prepaid For Land Use Right PrepaidForLandUseRight	15948501	usd
CY2022Q4	mhua	Prepaid For Property PrepaidForProperty	12323842	usd
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	1277150	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	28761901	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	1394539	usd
CY2022Q4	mhua	Less Noncurrent Portion LessNoncurrentPortion	12333122	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	16428779	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	1394539	usd
CY2018Q4	mhua	Land Use Right Agreements LandUseRightAgreements	the Company signed a land use right agreement with the government of Touqiao Town, Yangzhou City and paid RMB 50 million ($7.25 million) and RMB 60 million ($8.70 million), respectively, in 2018 and 2019 according to the agreement.
CY2020Q2	us-gaap	Deposits Paid For Securities Borrowed At Carrying Value DepositsPaidForSecuritiesBorrowedAtCarryingValue	85000000	cny
CY2020Q2	us-gaap	Deposits Paid For Securities Borrowed At Carrying Value DepositsPaidForSecuritiesBorrowedAtCarryingValue	12320000	usd
CY2020Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.035	pure
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	177474	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	305408	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	343795	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	224694	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12535348	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14063107	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3777301	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6585363	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8758047	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7477744	usd
CY2022	us-gaap	Depreciation Depreciation	541265	usd
CY2021	us-gaap	Depreciation Depreciation	595522	usd
CY2020	us-gaap	Depreciation Depreciation	497238	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	913097	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	15058	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	15058	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	15058	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	422310	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	497600	usd
CY2022Q4	mhua	Ownership Interest Percentage OwnershipInterestPercentage	0.25	pure
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	290	usd
CY2021Q4	us-gaap	Deposits Assets DepositsAssets	30599755	usd
CY2022Q4	us-gaap	Investments Investments	35000000	usd
CY2022Q4	us-gaap	Deposits Deposits	7000000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	4800000	usd
CY2022	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	4800000	usd
CY2022	mhua	Service Fee ServiceFee	2300000	usd
CY2022Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	42000000	cny
CY2022Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	6089428	usd
CY2021Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	33000000	cny
CY2021Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	5178420	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	191198	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	180744	usd
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	137160	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2777379	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2499131	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	96416	usd
CY2021Q4	us-gaap	Land Improvements LandImprovements	294582	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	2873795	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	2793713	usd
CY2022Q4	mhua	Long Term Bank Loan Total LongTermBankLoanTotal	5000000	cny
CY2022Q4	mhua	Long Term Bank Loan Total LongTermBankLoanTotal	724932	usd
CY2022Q4	mhua	Loan Agreement LoanAgreement	5000000	cny
CY2022Q4	mhua	Loan Agreement LoanAgreement	-724932	usd
CY2022Q4	mhua	Floating Interest Rate FloatingInterestRate	0.035	pure
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	3468	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	380926	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	488443	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	690824	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1521767	usd
CY2022	us-gaap	Taxes Other TaxesOther	59526	usd
CY2021	us-gaap	Taxes Other TaxesOther	72042	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	1131276	usd
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	2082252	usd
CY2022	mhua	Revenues Percentage RevenuesPercentage	0.165	pure
CY2017Q4	mhua	Assessable Profits AssessableProfits	2000000	hkd
CY2017Q4	mhua	Lower Tax Percentage LowerTaxPercentage	0.0825	pure
CY2017Q4	mhua	Remaining Taxable Income Percentage RemainingTaxableIncomePercentage	0.165	pure
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4713543	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5278462	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4688321	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	4713543	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	5278462	usd
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	4688321	usd
CY2022	mhua	Income Before Income Tax Provision IncomeBeforeIncomeTaxProvision	18129648	usd
CY2021	mhua	Income Before Income Tax Provision IncomeBeforeIncomeTaxProvision	26228041	usd
CY2020	mhua	Income Before Income Tax Provision IncomeBeforeIncomeTaxProvision	23733576	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3758113	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5605035	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4724933	usd
CY2022	us-gaap	Other Income OtherIncome	37169	usd
CY2021	us-gaap	Other Income OtherIncome	-13086	usd
CY2020	us-gaap	Other Income OtherIncome	-28392	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1660869	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	226222	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	313006	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	742608	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	539709	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	321226	usd
CY2022	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	4713543	usd
CY2021	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	5278462	usd
CY2020	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	4688321	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	1	pure
CY2022Q4	mhua	Enterprise Income Tax Percentage EnterpriseIncomeTaxPercentage	0.25	pure
CY2016Q4	mhua	Preferential Tax Percentage PreferentialTaxPercentage	0.15	pure
CY2021Q4	mhua	Preferential Tax Percentage PreferentialTaxPercentage	0.15	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.25	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.10	pure
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7515	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7839	usd
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7324	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	210000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.10	pure
CY2022Q4	us-gaap	Capital Leases Of Lessor Contingent Rentals Basis Spread On Variable Rate CapitalLeasesOfLessorContingentRentalsBasisSpreadOnVariableRate	0.50	pure
CY2022Q4	mhua	Reserve Tax Profit ReserveTaxProfit	0.50	pure
CY2022Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	15665860	usd
CY2021Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	15178467	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	29196	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	575901	usd
CY2020Q4	us-gaap	Other Receivables OtherReceivables	816607	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	2609755	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	18000000	cny
CY2022	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	2609755	usd
CY2022	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	18000000	cny
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2021Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23411068	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2021	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2021	mhua	Long Term Investment LongTermInvestment		usd
CY2020	mhua	Long Term Investment LongTermInvestment		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	mhua	Capital Contributed By Noncontrolling Shareholders CapitalContributedByNoncontrollingShareholders		usd
CY2020	mhua	Capital Contributed By Noncontrolling Shareholders CapitalContributedByNoncontrollingShareholders		usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	mhua	Proceeds From Issuance Of Shares ProceedsFromIssuanceOfShares		usd
CY2021	mhua	Proceeds From Issuance Of Shares ProceedsFromIssuanceOfShares		usd
CY2021	mhua	Shareholder Contribution Through Deferred Cost ShareholderContributionThroughDeferredCost		usd
CY2020	mhua	Shareholder Contribution Through Deferred Cost ShareholderContributionThroughDeferredCost		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes		usd
CY2021Q4	mhua	Prepaid For Land Use Right PrepaidForLandUseRight		usd
CY2021Q4	mhua	Prepaid For Property PrepaidForProperty		usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet		usd
CY2021Q4	mhua	Less Noncurrent Portion LessNoncurrentPortion		usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets		usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2020	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001835615

Files In Submission

Name	View Source	Status
0001213900-23-029709-index-headers.html	Edgar Link	pending
0001213900-23-029709-index.html	Edgar Link	pending
0001213900-23-029709.txt	Edgar Link	pending
0001213900-23-029709-xbrl.zip	Edgar Link	pending
f20f2022ex12-1_meihua.htm	Edgar Link	pending
f20f2022ex12-2_meihua.htm	Edgar Link	pending
f20f2022ex13-1_meihua.htm	Edgar Link	pending
f20f2022ex13-2_meihua.htm	Edgar Link	pending
f20f2022ex2-2_meihua.htm	Edgar Link	pending
f20f2022ex99-1_meihua.htm	Edgar Link	pending
f20f2022_meihua.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
img_003.jpg	Edgar Link	pending
img_004.jpg	Edgar Link	pending
img_005.jpg	Edgar Link	pending
img_006.jpg	Edgar Link	pending
img_007.jpg	Edgar Link	pending
img_008.jpg	Edgar Link	pending
img_009.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f20f2022_meihua_htm.xml	Edgar Link	completed
img_010.jpg	Edgar Link	pending
img_011.jpg	Edgar Link	pending
img_012.jpg	Edgar Link	pending
img_013.jpg	Edgar Link	pending
img_014.jpg	Edgar Link	pending
img_015.jpg	Edgar Link	pending
img_016.jpg	Edgar Link	pending
img_017.jpg	Edgar Link	pending
img_018.jpg	Edgar Link	pending
img_019.jpg	Edgar Link	pending
img_020.jpg	Edgar Link	pending
img_021.jpg	Edgar Link	pending
img_022.jpg	Edgar Link	pending
img_023.jpg	Edgar Link	pending
img_024.jpg	Edgar Link	pending
img_025.jpg	Edgar Link	pending
img_026.jpg	Edgar Link	pending
img_027.jpg	Edgar Link	pending
img_028.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mhua-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
mhua-20221231_def.xml	Edgar Link	unprocessable
mhua-20221231_lab.xml	Edgar Link	unprocessable
mhua-20221231_pre.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mhua-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MHUA
Meihua International Medical Technologies Co., Ltd. Stock $mhua

2022 Q4 Form 20-F Financial Statement

#000121390023029709 Filed on April 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHUA Meihua International Medical Technologies Co., Ltd. Stock $mhua

2022 Q4 Form 20-F Financial Statement

#000121390023029709 Filed on April 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHUA
Meihua International Medical Technologies Co., Ltd. Stock $mhua